Clinical Trials Directory

Trials / Unknown

UnknownNCT03321838

Office Based Vergence and Accommodative Therapy and Intermittent Exotropia

Pilot Study of Office Based Vergence and Accommodative Therapy as Treatment of Intermittent Exotropia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This pilot study is designed specifically to determine the short-term effect of OBVAT on intermittent exotropia in terms of 4 key areas (Standardizing reported outcomes of surgery for intermittent exotropia): control score, alignment, near stereoacuity and quality of life score. Result of this pilot study will be used to determine whether a full-scale RCT should be conducted to evaluate the short and long term effectiveness of OBVAT.

Detailed description

All enrolled px received 16-20 sessions of OBVAT, 60 minutes per visit, one time per week; Home reinforcement, 15 minutes each time, five times per week. 1. Primary outcome measure: A. Change in the office based intermittent exotropia control score 2. Secondary outcome measures A. Change in Look And Cover, then Ten seconds of Observation Scale for Exotropia (LACTOSE) B. Change in Newcastle Control Score (NCS) C. Change in Chinese intermittent exotropia questionnaire (CIXTQ) D. Change in near stereopsis by Preschool randot near stereoacuity E. Change in size of distant deviation angle by prism alternating cover test F. Change in size of near deviation angle by prism alternating cover test

Conditions

Interventions

TypeNameDescription
BEHAVIORALaccommodative/vergence therapyAccommodative/vergence therapy (60 minutes per visit, one time per week, 12-14 weeks) and home reinforcement (15 minutes each time, five times per week, 12-14 weeks) will be provided to patients of treatment group. These therapy includes accommodative, vergence and anti-suppression technique. No drug is used during the whole therapy process.

Timeline

Start date
2017-11-01
Primary completion
2018-01-31
Completion
2018-12-30
First posted
2017-10-26
Last updated
2018-06-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03321838. Inclusion in this directory is not an endorsement.